Title of article :
Severe Diabetic Ketoacidosis and Coronavirus 2019 (COVID-19) Infection led to Diagnosis of Autoimmune Polyglandular Syndrome
Author/Authors :
Tavakoli ، Meraj Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital - Tehran University of Medical Sciences , Rabizadeh ، Soghra Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital - Tehran University of Medical Sciences , Seifouri ، Sara Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital - Tehran University of Medical Sciences , Esteghamati ، Alireza Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital - Tehran University of Medical Sciences , Nakhjavani ، Manouchehr Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital - Tehran University of Medical Sciences
Abstract :
To this day, millions of people in the world have been diagnosed with corona virus 2019 (COVID-19). This disease cannot only lead to higher mortality rates among those with underlying Diabetes Mellitus (DM), but also may trigger DM in susceptible patients. Therefore, incidence of new-onset DM increased during the pandemic as a result; treatment of patients with diabetes and COVID-19 is important and needs further investigations. Here, we report a 27-year- old woman with past medical history of premature ovarian failure (POF) since14 years ago, who initially presented with severe diabetic ketoacidosis (DKA) which was triggered by COVID-19 and later through her lab results hypoparathyroidism was also detected. She was treated for DKA and COVID-19 Infection concomitantly, and she was also diagnosed with autoimmune polyglandular syndrome due to her multiple autoimmune endocrine organ involvements.
Keywords :
COVID , 19 , Diabetic ketoacidosis , Newly diagnosed diabetes , Autoimmune polyglandular syndrome , Case report
Journal title :
Case Reports in Clinical Practice
Journal title :
Case Reports in Clinical Practice